| pubmed-article:17823908 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0001792 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C1516224 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C1831741 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0796493 | lld:lifeskim |
| pubmed-article:17823908 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17823908 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:17823908 | pubmed:dateCreated | 2007-10-25 | lld:pubmed |
| pubmed-article:17823908 | pubmed:abstractText | The aim of this study was to compare the efficacy of single-agent weekly docetaxel with the combination of docetaxel and gemcitabine in elderly and/or poor performance status patients with advanced nonsmall cell lung cancer (NSCLC). | lld:pubmed |
| pubmed-article:17823908 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17823908 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17823908 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:17823908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17823908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17823908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17823908 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17823908 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17823908 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:17823908 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:HainsworthJoh... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:SpigelDavid... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:FarleyCindyC | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:ShipleyDianna... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:BeardenJames... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:GandhiJitendr... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:Ann... | lld:pubmed |
| pubmed-article:17823908 | pubmed:author | pubmed-author:Anthony... | lld:pubmed |
| pubmed-article:17823908 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17823908 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:17823908 | pubmed:volume | 110 | lld:pubmed |
| pubmed-article:17823908 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17823908 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17823908 | pubmed:pagination | 2027-34 | lld:pubmed |
| pubmed-article:17823908 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:meshHeading | pubmed-meshheading:17823908... | lld:pubmed |
| pubmed-article:17823908 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17823908 | pubmed:articleTitle | Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. | lld:pubmed |
| pubmed-article:17823908 | pubmed:affiliation | Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee, USA. jhainsworth@tnonc.com | lld:pubmed |
| pubmed-article:17823908 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17823908 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:17823908 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:17823908 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:17823908 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17823908 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17823908 | lld:pubmed |
